The Vanderbilt Genetics Institute is the intellectual hub for genomics research at Vanderbilt University Medical Center and Vanderbilt University.
A new study will use innovative methods developed at VUMC to look for drugs already approved for other uses that could potentially be repurposed to treat Alzheimer’s.
The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer.
The Young Physician-Scientist Award recognizes “notable achievements” by researchers who are within five years of their first faculty appointment.
They are among more than 3,500 ASCI members, 48 of whom are current, full-time faculty members of the Vanderbilt University School of Medicine.
With funding from the newly established Sarah Kyle Anorexia Nervosa Research Foundation, the researchers hope to identify biomarkers that will point to novel targets for prevention and treatment.